Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Preferred Stock Liabilities (2018 - 2019)

TELA Bio (TELA) has 2 years of Preferred Stock Liabilities data on record, last reported at $145.4 million in Q3 2019.

  • For Q3 2019, Preferred Stock Liabilities rose 67.32% year-over-year to $145.4 million; the TTM value through Sep 2019 reached $145.4 million, up 67.32%, while the annual FY2018 figure was $1.6 million, 94.7% down from the prior year.
  • Preferred Stock Liabilities reached $145.4 million in Q3 2019 per TELA's latest filing, up from $107.1 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $145.4 million in Q3 2019 and bottomed at $1.6 million in Q4 2018.